Two Sigma Securities’s 10x Genomics TXG Stock Holding History

Two Sigma Securities’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,000	Closed	-$304K	–	2849
2022 Q1	$304K	Buy	+4,000	New	+$350K	0.01%	1396

Other funds holding TXG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's TXG Position: Q4 2025 in Review

Two Sigma Securities sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 13,431 shares — an estimated $157K sold.

Two Sigma Securities first reported a position in TXG in Q4 2019 and held it in 6 quarters. The position peaked at $471K in Q4 2021. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

Two Sigma Securities reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
Two Sigma Securities sold 13,431 10x Genomics shares in Q4 2025, an estimated $157K.
Two Sigma Securities first reported a position in 10x Genomics in Q4 2019 and held it in 6 quarters.
Two Sigma Securities's 10x Genomics position peaked at $471K in Q4 2021.
322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.